Frontiers in Medicine· 2026Q1
Öksürük Seslerini Kullanarak Solunum Yolu Hastalıklarının Taranması ve Tanısına Yardımcı Olmak İçin Swaasa Yapay Zeka Platformunun Klinik Doğrulaması
Clinical validation of the Swaasa® artificial intelligence platform using cough sounds for screening and aid in diagnosis of respiratory diseases
- 2atıf
- Q1SCImago
- 2026yıl
Kısa özet
Swaasa Yapay Zeka platformu, öksürük seslerini kullanarak normal ve anormal solunum yolu durumlarını (%90 doğrulukla) ve spirometri paternlerini (%79-84 doğruluk) ve hastalık tiplerini (%83-93 doğruluk) doğru bir şekilde ayırt etmektedir.
Yapay zekâ ile başlık ve abstract'tan üretildi; tam metin okunmaz.
Ana noktalar
- Swaasa Yapay Zeka platformu, normal ve anormal solunum yolu durumlarını ve spirometriyi ayırt etmede %90 doğruluk elde etti.
- Çok sınıflı sonuçlar için doğruluk, spirometri paternleri için %79-84 ve patern şiddeti için %76-84.5 arasında değişti.
- Astım, KOAH, İAH ve Bronşektazi için hastalık sınıflandırma doğruluğu %83 ile %93 arasında gerçekleşti.
- Performans, yaş, cinsiyet ve BKİ gibi demografik parametreler arasında tutarlı kaldı.
Yapay zekâ ile başlık ve abstract'tan üretildi; tam metin okunmaz.
Özet (abstract)
Abstract Introduction Analysis of cough sounds have the potential to give a clue regarding the underlying respiratory disease. The Swaasa AI platform using artificial intelligence technology can analyze the cough sounds and provides an output using cough as a marker. The Swaasa AI platform comes under the category of Software As a Medical Device (SaMD), the device can detect underlying respiratory condition as normal vs abnormal, the pattern of disease condition (obstructive, restrictive or normal), the severity of pattern (mild, moderate, severe) and presence of disease conditions for Asthma, COPD, ILD and Bronchiectasis. Methods Patients (age >= 18 years) presenting to our departments with respiratory symptoms were prospectively recruited into the study. The patient’s cough sound was recorded by a mobile device in which the Swaasa AI platform was installed. Spirometry was done and patients’ clinical diagnosis was taken as reference standard for comparison. Polychotomous variables were analyzed in binary form as normal and abnormal. Multi-class outcomes were defined as obstructive, restrictive, or normal pattern, mild-moderate-severe as pattern severity or disease conditions like Asthma, COPD, ILD and Bronchiectasis. Results We recruited 2179 patients with respiratory diseases and 827 normal individuals. Sixty-two percent of them were males. The Swaasa AI platform has 90% accuracy in distinguishing normal versus abnormal (having respiratory condition) as well as distinguishing normal from abnormal spirometry. The performance was consistent across demographic parameters such as age, gender, and BMI. The accuracy for multi-class outcomes were between 79%-84% for spirometry pattern and 76%-84.5% for pattern severity and 83%-93% for disease type classification. Conclusion Swaasa commends an elevated level of precision in classifying normal and abnormal conditions across demographic subgroups indicating its promise as a screening tool. While the accuracy measures emphasize further refinement to ensure consistent high performance across disease scenarios and severity levels, the study shows Swaasa’s reasonable potential in identification of specific respiratory diseases and their severity.
Yazarların özeti; kaynağından alınmıştır. Frontiers in Medicine, 2026 · DOI ↗
Ücretsiz hesapla devam et
Makaleye Sor ile bu makaleye günde 3 soru ücretsiz; makaleyi kaydet, kaynakçasını al, ilgi alanına göre her gün yeni özetler. Çıkarımlar Premium.
Web'de ücretsiz devam etGoogle ya da Apple hesabınla giriş; kart istemez. Bu makaleye geri dönersin.
Telefonda:
Alan: Göğüs ve Solunum Tıbbı
Pulmonary and Respiratory MedicineMedicine